إعلان
إعلان

SION

SION logo

Sionna Therapeutics, Inc. Common Stock

39.23
USD
برعاية
+2.63
+7.19%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

39.09

-0.14
-0.35%

تقارير أرباح SION

النسبة الإيجابية المفاجئة

SION تفوق 2 من 4 آخر التقديرات.

50%

التقرير التالي

بيانات التقرير القادم
١٦ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.55
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
+19.57%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-83.73%

Sionna Therapeutics, Inc. Common Stock earnings per share and revenue

On ٠٥ نوفمبر ٢٠٢٥, SION reported earnings of -0.46 USD per share (EPS) for Q3 25, beating the estimate of -0.49 USD, resulting in a 6.88% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.57% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 المحللين forecast an EPS of -0.55 USD, with revenue projected to reach -- USD, implying an زيادة of 19.57% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Sionna Therapeutics, Inc. Common Stock reported EPS of -$0.46, beating estimates by 6.88%, and revenue of $0.00, 0% as expectations.
The stock price moved down -1.57%, changed from $35.64 before the earnings release to $35.08 the day after.
The next earning report is scheduled for ١٦ مارس ٢٠٢٦.
Based on 11 المحللين, Sionna Therapeutics, Inc. Common Stock is expected to report EPS of -$0.55 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان